ImaRx Investments Receives ISO-7 Certification for Its GMP Manufacturing Suite

ImaRx Investments, LLC, an investment firm based in Tucson, Arizona, has received ISO-7 certification on February 1st for its GMP manufacturing suite. The 1,800 square foot, ISO-5 capable clean room is designed for manufacturing injectable drugs. The facility is the only one of its kind in Southern Arizona. The facility is jointly leased by two Tucson-based biotechnology companies, Microvascular Therapeutics (MVT) and NuvOx Pharma.

Recent Posts

See All

Microvascular Therapeutics and Cordance Medical Announce Strategic Partnership

Tucson, AZ & Mountain View, CA – Microvascular Therapeutics (MVT), a pioneering healthcare research and development company, is pleased...

MVT and Soundjet Announce Collaboration Aiming to Bring New Treatment Options to Patients with Vascular Thrombosis

Microvascular Therapeutics, Inc. (MVT), and SoundJet Medical, Inc. (SoundJet) announce that they have entered into a strategic...

Microvascular Therapeutics Announce Completion of Phase 2 Study Enrollment for MVT-100

Tucson, AZ – Microvascular Therapeutics (MVT), a pioneering healthcare research and development company, is pleased to announce the...

ImaRx Investments Receives ISO-7 Certification for Its GMP Manufacturing Suite

Recent Posts

Comments